Temporal trends in outcomes for infants with neonatal opioid withdrawal managed with the Finnegan scoring tool: Insights from the INFORM NOW Study

OBJECTIVE: To evaluate changes in hospital outcomes for infants with neonatal opioid withdrawal syndrome (NOWS) assessed by the Finnegan Tool before (10/1/2019 to 12/31/2019;pre-epoch) and after (7/1/2021 to 3/31/2022;post-epoch) publication of the 2020 AAP NOWS clinical report. STUDY DESIGN: This subgroup analysis included infants with NOWS assessed with the Finnegan Tool and enrolled in the INFORM NOW study (pre- and post-epoch 183 and 267 infants respectively). RESULTS: No differences were found between epochs in initiation or length of pharmacologic treatment(LOT), or length of stay(LOS). Outcomes were modified by opioid type: LOT was 20% shorter (aMR=0.80; 95%CI:[0.69,0.93]) and LOS was 16% shorter (aMR=0.84; 95%CI:[0.73,0.96]) for buprenorphine treated infants post- compared to pre-epoch, while LOT and LOS were longer in the post-epoch for those treated with methadone. CONCLUSION: There was no difference in outcomes before and after publication of the AAP report. However, the type of postnatal opioid did modify study results.

Authors

Institutions

Publication Details

Journal
Journal of Perinatology
Published
2026-04-16
DOI
https://doi.org/10.1038/s41372-026-02644-7
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Temporal trends in outcomes for infants with neonatal opioid withdrawal managed with the Finnegan scoring tool: Insights from the INFORM NOW Study

Lori A. Devlin, Stephanie L. Merhar, Denise C. Babineau, Richard Hall et al.
Journal of Perinatology
Prenatal Substance Exposure Effects
article

Temporal trends in outcomes for infants with neonatal opioid withdrawal managed with the Finnegan scoring tool: Insights from the INFORM NOW Study

Lori A. Devlin, Stephanie L. Merhar, Denise C. Babineau, Richard Hall, Abhik Das, Walter K. Kraft, Sara B. DeMauro, Lawrence Leeman, Namasivayam Ambalavanan, Gregory M. Sokol, Sucheta Telang, E. Leeon Rhodes, Brenda Poindexter, Jonathan M. Davis, Margaret Crawford, Scott A. Lorch, Augusto Santos Schmidt
article en

Abstract

OBJECTIVE: To evaluate changes in hospital outcomes for infants with neonatal opioid withdrawal syndrome (NOWS) assessed by the Finnegan Tool before (10/1/2019 to 12/31/2019;pre-epoch) and after (7/1/2021 to 3/31/2022;post-epoch) publication of the 2020 AAP NOWS clinical report. STUDY DESIGN: This subgroup analysis included infants with NOWS assessed with the Finnegan Tool and enrolled in the INFORM NOW study (pre- and post-epoch 183 and 267 infants respectively). RESULTS: No differences were found between epochs in initiation or length of pharmacologic treatment(LOT), or length of stay(LOS). Outcomes were modified by opioid type: LOT was 20% shorter (aMR=0.80; 95%CI:[0.69,0.93]) and LOS was 16% shorter (aMR=0.84; 95%CI:[0.73,0.96]) for buprenorphine treated infants post- compared to pre-epoch, while LOT and LOS were longer in the post-epoch for those treated with methadone. CONCLUSION: There was no difference in outcomes before and after publication of the AAP report. However, the type of postnatal opioid did modify study results.

Journal of Perinatology
Cincinnati Children's Hospital Medical Center (US), Tufts Medical Center (US), National Institutes of Health (US), Children's Hospital of Philadelphia (US), University of Louisville (US), Thomas Jefferson University (US), Emory University (US), University of New Mexico (US), RTI International (US), University of Alabama at Birmingham (US), RTI Health Solutions (US), Perinatal Institute (GB), Eunice Kennedy Shriver National Institute of Child Health and Human Development (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), University of Pennsylvania (US), University of Arkansas for Medical Sciences (US)
U.S. Department of Health and Human Services, Children's Hospital of Philadelphia, University of Pennsylvania, Emory University, Cincinnati Children's Hospital Medical Center, University of Louisville, University of Cincinnati, RTI International, Thomas Jefferson University, Children’s Hospital of Wisconsin Research Institute, Children's Healthcare of Atlanta, Children's of Alabama, National Institutes of Health, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Good health and well-being
Openalex Percentile: Top 17%
Prenatal Substance Exposure Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.